Brief: Basilea Pharmaceutica Sales Trigger Milestone From Pfizer To Basilea Of USD 10 Million

Basilea Pharmaceutica AG, Allschwil

09/02/2021 06:16

Feb 9 (Reuters) - BASILEA PHARMACEUTICA AG  BSLN.S :
    * SALES TRIGGER MILESTONE FROM PFIZER TO BASILEA OF USD 10
MILLION
    * ANNOUNCED TODAY THAT SALES OF ANTIFUNGAL CRESEMBA(®)
(ISAVUCONAZOLE) BY PFIZER IN EUROPE AND ISRAEL EXCEEDED
THRESHOLD TRIGGERING A MILESTONE PAYMENT TO BASILEA OF USD 10
MILLION
    * UNDER AGREEMENT, SALES MILESTONES TOTALING USD 12 MILLION
WERE
TRIGGERED IN 2019 AND REGULATORY AND COMMERCIAL MILESTONES
TOTALING AROUND USD 6 MILLION WERE TRIGGERED IN 2020
    * BASILEA IS ENTITLED TO RECEIVE MILESTONE PAYMENTS UPON
PFIZER'S
CUMULATIVE CRESEMBA SALES IN PFIZER'S LICENSED TERRITORIES
EXCEEDING CERTAIN THRESHOLDS
    * STILL ELIGIBLE FOR REGULATORY AND SALES MILESTONE PAYMENTS
OF UP
TO APPROXIMATELY USD 620 MILLION, IN ADDITION TO RECEIVING
MID-TEEN ROYALTIES ON SALES
    * MILESTONE PAYMENTS OF UP TO APPROXIMATELY USD 620 MILLION,
IN
ADDITION TO RECEIVING MID-TEEN ROYALTIES ON SALES

Source text for Eikon:  ID:nGNE1qnDNF 
Further company coverage:  BSLN.S 
    

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))